An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

major depressive disorder (mdd), major depressive disorder with anxious distress, major depressive disorder, depressive disorder, depression, anxiety, mood disorders, spt-300, lyt-300, glyphallo, glyph allopregnanolone, buoy-1 ole study